MedPath

FERNDALE LABORATORIES, INC.

🇺🇸United States
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

2

Active:0
Completed:2

Trial Phases

2 Phases

Phase 4:1
Not Applicable:1

Drug Approvals

0

Drug Approvals

No drug approvals found

This company may not have drug approvals in our database

Clinical Trials

Distribution across different clinical trial phases (2 trials with phase data)• Click on a phase to view related trials

Not Applicable
1 (50.0%)
Phase 4
1 (50.0%)

A Multicenter Study of 074-6751 Lotion in Subjects With Moderate Plaque Psoriasis

Not Applicable
Completed
Conditions
Plaque Psoriasis
First Posted Date
2017-05-30
Last Posted Date
2018-04-12
Lead Sponsor
Ferndale Laboratories, Inc.
Target Recruit Count
95
Registration Number
NCT03167515
Locations
🇺🇸

Site 03, Tampa, Florida, United States

🇺🇸

Site 04, Carmel, Indiana, United States

🇺🇸

Site 05, Plainfield, Indiana, United States

and more 2 locations

LMX-4 for Postoperative Pain Management in Infants and Children Undergoing Penoplasty Surgery

Phase 4
Completed
Conditions
Post-Operative Pain
Interventions
Drug: LMX4
Drug: LMX4 Placebo
First Posted Date
2009-02-19
Last Posted Date
2011-07-01
Lead Sponsor
Ferndale Laboratories, Inc.
Target Recruit Count
50
Registration Number
NCT00847093
Locations
🇺🇸

Children's Memorial Hospital, Chicago, Illinois, United States

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.